The Orreco team has been conducting research in the high-performance environment for more than 20 years, publishing over 400 peer-reviewed papers. This evidence base is the foundation of our products and services.
Performance prediction for quality recommendations.
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CAR) analysis.
Prognostic significance of deregulated dicer expression in breast cancer.
Seasonal Vitamin D status the effectiveness of winter supplementation in elite athletes in the UK.